Yu MC, Yuan J-M, Ross, RK (1999) Epidemiology of renal cell carcinoma. In: Petrovich Z, Baert L, Brady LW, eds. Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies. Innovations in Management. Berlin: Springer-Verlag, pp. 3-13.
Yuan J-M, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC (1998) Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77: 1508-1513.
Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE (1986) Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 77: 351-356.
Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States JAMA 281: 1628-1631.
National Center for Health Statistics (1998) Health, United States. Hyattsville, MD: National Center for Health Statistics.
Kumar KV, Das UN (1993) Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19: 59-66.
Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M (1994) Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107: 71-84.
Van Gaal LF, Vertommen J, De Leeuw IH (1998) The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 137: S39-S44.
Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O (1987) Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 47: 1867-1869.
Okada S, Hamazaki S, Ebina Y, Li JL, Midorikawa O (1987) Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation. Biochim Biophys Acta 922: 28-33.
Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 91: 2616-2620.
Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC (1997) Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 22: 1019-1027.
Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20: 553-566.
Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y (1990) Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis 11: 345-347.
Toyokuni S, Mori T, Dizdaroglu M (1994) DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 57: 123-128.
Umemura T, Hasegawa R, Sai-Kato K, et al. (1996) Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn J Cancer Res 87: 882-886.
Yu MC, Ross RK (1998) Epidemiology of bladder cancer. In: Petrovich Z, Baert L, and Brady LW, eds. Carcinoma of the Bladder. Innovations in Management. Berlin: Springer-Verlag, pp. 1-13.
Okamoto K, Toyokuni S, Uchida K, et al. (1994) Formation of 8-hydroxy-2¢-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 58: 825-829.
Basso D, Panozzo MP, Plebani M, et al. (1994) Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship? J Med 25: 91-104.
Lindblad P, Mellemgaard A, Schlehofer B, et al. (1995) International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61: 192-198.
Chow W-H, McLaughlin JK, Mandel JS, Blot WJ, Niwa S, Fraumeni JF Jr (1995) Reproductive factors and the risk of renal cell cancer among women. Int J Cancer 60: 321-324.
Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC (1999) Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 8: 999-1003.
Yagi K (1997) Female hormones act as natural antioxidants-a survey of our research. Acta Biochim Pol 44: 701-709.
Yuan J-M, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK (1998) Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 7: 429-433.
Miller ER III, Appel LJ, Jiang L, Risby TH (1997) Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 96: 1097-1101.
Lindblad P, Chow WH, Chan J, et al. (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107-112.
Schlehofer B, Pommer W, Mellemgaard A, et al. (1996) International renal-cell-cancer study. VI. The role of medical and family history. Int J Cancer 66: 723-726.
Jain SK, McVie R, Jaramillo JJ, et al. (1996) The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 31: S87-S90.
Lindblad P, Wolk A, Bergstrom R, Adami H-O (1997) Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 6: 215-223.
Yuan J-M, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC (1998) Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 77: 211-216.
Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H (1997) Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 57: 2410-2414.
Moore K, Roberts LJ 2nd (1998) Measurement of lipid peroxidation. Free Radic Res 28: 659-671.
Janero DR (1990) Malondialdehyde and thiobarbituric acidreactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9: 515-540.
Iversen SA, Cawood P, Dormandy TL (1985) A method for the measurement of a diene-conjugated derivative of linoleic acid, 292 M. Gago-Dominguez et al. 18:2(9,11), in serum phospholipid, and possible origins. Ann Clin Biochem 22: 137-140.
Thompson S, Smith MT (1985) Measurement of the diene conjugated form of linoleic acid in plasma by high performance liquid chromatography: a questionable non-invasive assay of free radical activity? Chem Biol Interact 55: 357-366.
Kuno T, Hozumi M, Morinobu T, Murata T, Mingci Z, Tamai H (1998) Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls. Free Radic Res 28: 81-86.
Vasankari T, Fogelholm M, Oja P, Vuori I, Ahotupa M (1997) Effect of weight reduction on LDL oxidation. Med Sci Sports Exerc 29: S130.
Vasankari TJ, Kujala UM, Vasankari TM, Ahotupa M (1998) Reduced oxidized LDL levels after a 10-month exercise program. Med Sci Sports Exerc 30: 1496-1501.
Usyal M, Bulur H, Sener D, Oz H (1986) Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol 24: 474-476.
Sharma RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q (1992) Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries. Role of oxygen free radicals. Arterioscler Thromb 12: 403-415.
Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL (1997) Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 30: 569-575.
Hayek T, Attias J, Smith J, Breslow JL, Keidar S (1998) Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 31: 540-544.
Wang YP, Walsh SW, Guo JD, Zhang JY (1991) The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165: 1695-1700.
Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O (1986) Nephrotoxicity and renal cell carcinoma after use of ironand aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76: 107-113.
Okada S, Midorikawa O (1982) Induction of the rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med 29: 485-491.
Okada S, Hamazaki S, Ebina Y, Fujioka M, Midorikawa O (1983) Nephrotoxicity and induction of the renal adenocarcinoma by ferric nitriloacetate (Fe-NTA) in rats. In: Urushizaki I, Aisen P, Litowsky I, Drysdale JW, eds. Structure and Function of Iron Storage and Transport Proteins. New York: Elsevier, pp. 473-478.
Ebina Y, Okada S, Hamazaki S, Midorikawa O (1984) Liver, kidney, and central nervous system toxicity of aluminum given intraperitoneally to rats: a multiple-dose subchronic study using aluminum nitrilotriacetate. Toxicol Appl Pharmacol 75: 211-218.
Toyokuni S, Okada S, Hamazaki S, et al. (1990) Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice [published erratum appears in Cancer Res 1992; 52: 6136]. Cancer Res 50: 5574-5580.
Toyokuni S, Mori T, Hiai H, Dizdaroglu M (1995) Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer 62: 309-313.
Uchida K, Fukuda A, Kawakishi S, Hiai H, Toyokuni S (1995) A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys 317: 405-411.
Deguchi J, Miyamoto M, Okada S (1995) Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats. Jpn J Cancer Res 86: 1068-1071.
Sai K, Tyson CA, Thomas DW, Dabbs JE, Hasegawa R, Kurokawa Y (1994) Oxidative DNA damage induced by potassium bromate in isolated rat renal proximal tubules and renal nuclei. Cancer Lett 87: 1-7.
Liu M, Okada S (1994) Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N¢-diacetate. Carcinogenesis 15: 2817-2821.
Kirillov VN (1988) Effect of phenozan on nitrosodimethylamineinduced carcinogenesis in rat kidneys. Eks Onkol 10: 23-26 (in Russian with English abstract).
Li J L, Okada S, Hamazaki S, Deng IL, Midorikawa O (1988) Sex differences in ferric nitrilotriacetate-induced lipid peroxidation and nephrotoxicity in mice. Biochim Biophys Acta 963: 82-87.
Okada S, Fukunaga Y, Hamazaki S, Yamada Y, Toyokuni S (1991) Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney. Acta Pathol Jpn 41: 221-226.
Wang MY, Liehr JG (1995) Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 16: 1941-1945.
Cortes-Vizcaino V, Peydro-Olaya A, Llombart-Bosch A (1994) Morphological and immunohistochemical support for the interstitial cell origin of oestrogen-induced kidney tumours in the Syrian golden hamster. Carcinogenesis 15: 2155-2162.
Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA (1993) Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 4: 101-110.
Sack MN, Rader DJ, Cannon RO 3rd (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343: 269-270.
Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti GM, Nath KA (1996) Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271: F814-F823.
Wang YP, Walsh SW, Guo JD, Zhang JY (1991) Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 165: 1690-1694.
al Senaidy AM, al Zahrany YA, al Faqeeh MB (1997) Effects of smoking on serum levels of lipid peroxides and essential fat-soluble antioxidants. Nutr Health 12: 55-65.
Liu CS, Chen HW, Lii CK, Chen SC, Wei YH (1998) Alterations of small-molecular-weight antioxidants in the blood of smokers. Chem Biol Interact 116: 143-154.
Fuller CJ, Grundy SM, Norkus EP, Jialal I (1996) Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 119: 139-150.
Gnarra JR, Tory K, Weng Y, et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet 7: 85-90.